标题
Avoiding Drug Resistance in HIV Reverse Transcriptase
作者
关键词
-
出版物
CHEMICAL REVIEWS
Volume -, Issue -, Pages -
出版商
American Chemical Society (ACS)
发表日期
2021-01-29
DOI
10.1021/acs.chemrev.0c00967
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Structural basis for strand-transfer inhibitor binding to HIV intasomes
- (2020) Dario Oliveira Passos et al. SCIENCE
- Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial
- (2020) Dirk Schürmann et al. Lancet HIV
- Evolving understanding of HIV-1 reverse transcriptase structure, function, inhibition, and resistance
- (2020) Francesc Xavier RUIZ et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
- (2020) Calvin J. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
- (2020) Richard T. Eastman et al. ACS Central Science
- CMCdG, a novel nucleoside analog, exerts potent activity against wild-type and entecavir-resistant HBV with favorable safety feature
- (2019) Nobuyo Higashi-Kuwata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Active-site deformation in the structure of HIV-1 RT with HBV-associated septuple amino acid substitutions rationalizes the differential susceptibility of HIV-1 and HBV against 4ʹ-modified nucleoside RT inhibitors
- (2019) Yoshiaki Yasutake et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Once-Weekly Oral Dosing of MK-8591 Protects Male Rhesus Macaques From Intrarectal Challenge With SHIV109CP3
- (2019) Martin Markowitz et al. JOURNAL OF INFECTIOUS DISEASES
- Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus
- (2019) Enzo Tramontano et al. ANTIVIRAL RESEARCH
- Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment
- (2019) Yali Wang et al. Expert Opinion on Drug Metabolism & Toxicology
- Human Immunodeficiency Virus-1 Viral Load Is Elevated in Individuals With Reverse-Transcriptase Mutation M184V/I During Virological Failure of First-Line Antiretroviral Therapy and Is Associated With Compensatory Mutation L74I
- (2019) J Gregson et al. JOURNAL OF INFECTIOUS DISEASES
- Structural Basis of HIV-1 Inhibition by Nucleotide-Competing Reverse Transcriptase Inhibitor INDOPY-1
- (2019) F. Xavier Ruiz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Determinants of Active-Site Inhibitor Interaction with HIV-1 RNase H
- (2019) Zhaoyong Xi et al. ACS Infectious Diseases
- Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): Our past twenty years
- (2019) Chunlin Zhuang et al. Acta Pharmaceutica Sinica B
- Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H
- (2019) Lei Wang et al. ACCOUNTS OF CHEMICAL RESEARCH
- Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality
- (2018) Angie N. Pinto et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Extended Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and Prevention
- (2018) Stephanie E. Barrett et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structure-based design of targeted covalent inhibitors
- (2018) Richard Lonsdale et al. CHEMICAL SOCIETY REVIEWS
- Update on Recent Developments in Small Molecular HIV-1 RNase H Inhibitors (2013-2016): Opportunities and Challenges
- (2018) Xueshun Wang et al. CURRENT MEDICINAL CHEMISTRY
- 6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones potently and selectively inhibited HIV reverse transcriptase-associated RNase H
- (2018) Lei Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Emerging reverse transcriptase inhibitors for HIV-1 infection
- (2018) Mohammad A. Rai et al. EXPERT OPINION ON EMERGING DRUGS
- Pharmacokinetics studies of 4′-cyano-2′-deoxyguanosine, a potent inhibitor of the hepatitis B virus, in rats
- (2018) Mai Hashimoto et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
- (2018) Maria L. Agostini et al. mBio
- 4′-Ethynyl-2-fluoro-2′-deoxyadenosine, MK-8591
- (2018) Martin Markowitz et al. Current Opinion in HIV and AIDS
- The Transmission and Evolution of HIV-1 Quasispecies within One Couple: a Follow-up Study based on Next-Generation Sequencing
- (2018) Fengjiao Yu et al. Scientific Reports
- The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic
- (2018) Vigneshwaran Namasivayam et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H
- (2017) Jayakanth Kankanala et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Double-Winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity
- (2017) Sanjeev Kumar V. Vernekar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: From design to protein crystallography
- (2017) Albert H. Chan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A supramolecular assembly mediates lentiviral DNA integration
- (2017) Allison Ballandras-Colas et al. SCIENCE
- Redox-based reagents for chemoselective methionine bioconjugation
- (2017) Shixian Lin et al. SCIENCE
- Targeted Covalent Inhibitors for Drug Design
- (2016) Thomas A. Baillie ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Doravirine Suppresses Common Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutants at Clinically Relevant Concentrations
- (2016) Meizhen Feng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibition of HIV-1 Reverse Transcriptase Dimerization by Small Molecules
- (2016) Cristina Tintori et al. CHEMBIOCHEM
- Rilpivirine and Doravirine have complementary efficacies against NNRTI-Resistant HIV-1 mutants
- (2016) Steven J. Smith et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions
- (2016) Paul A. Jackson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H
- (2016) Jayakanth Kankanala et al. JOURNAL OF MEDICINAL CHEMISTRY
- Computational protein–ligand docking and virtual drug screening with the AutoDock suite
- (2016) Stefano Forli et al. Nature Protocols
- Structural basis of HIV inhibition by translocation-defective RT inhibitor 4′-ethynyl-2-fluoro-2′-deoxyadenosine (EFdA)
- (2016) Zhe Li Salie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Allosteric HIV-1 integrase inhibitors promote aberrant protein multimerization by directly mediating inter-subunit interactions: Structural and thermodynamic modeling studies
- (2016) Nanjie Deng et al. PROTEIN SCIENCE
- Design, Conformation, and Crystallography of 2-Naphthyl Phenyl Ethers as Potent Anti-HIV Agents
- (2016) Won-Gil Lee et al. ACS Medicinal Chemistry Letters
- Pharmacokinetics of Long-Acting Tenofovir Alafenamide (GS-7340) Subdermal Implant for HIV Prophylaxis
- (2015) Manjula Gunawardana et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Subtype-Specific Analysis of the K65R Substitution in HIV-1 That Confers Hypersusceptibility to a Novel Nucleotide-Competing Reverse Transcriptase Inhibitor
- (2015) Hong-Tao Xu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oral Administration of the Nucleoside EFdA (4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine) Provides Rapid Suppression of HIV Viremia in Humanized Mice and Favorable Pharmacokinetic Properties in Mice and the Rhesus Macaque
- (2015) Cheryl A. Stoddart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Alternative divalent cations (Zn2+, Co2+, and Mn2+) are not mutagenic at conditions optimal for HIV-1 reverse transcriptase activity
- (2015) Vasudevan Achuthan et al. BMC BIOCHEMISTRY
- Predicted residual activity of rilpivirine in HIV-1 infected patients failing therapy including NNRTIs efavirenz or nevirapine
- (2015) K. Theys et al. CLINICAL MICROBIOLOGY AND INFECTION
- Covalent protein modification: the current landscape of residue-specific electrophiles
- (2015) D Alexander Shannon et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Pre-Exposure Prophylaxis to Prevent HIV Infection: Current Status, Future Opportunities and Challenges
- (2015) Douglas S. Krakower et al. DRUGS
- 4′-modified nucleoside analogs: Potent inhibitors active against entecavir-resistant hepatitis B virus
- (2015) Yuki Takamatsu et al. HEPATOLOGY
- Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
- (2015) Paul E Sax et al. LANCET
- HIV-1 assembly, release and maturation
- (2015) Eric O. Freed NATURE REVIEWS MICROBIOLOGY
- Identification of mechanistically distinct inhibitors of HIV-1 reverse transcriptase through fragment screening
- (2015) Jennifer La et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of Highly Conserved Residues Involved in Inhibition of HIV-1 RNase H Function by Diketo Acid Derivatives
- (2014) Angela Corona et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Drug Resistance-Associated Amino Acid Changes in HIV-1 Subtype C on Susceptibility to Newer Nonnucleoside Reverse Transcriptase Inhibitors
- (2014) Adriaan E. Basson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroResistance Selection with Doravirine (MK-1439), a Novel Nonnucleoside Reverse Transcriptase Inhibitor with Distinct Mutation Development Pathways
- (2014) Meizhen Feng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent Progress in the Research of Small Molecule HIV-1 RNase H Inhibitors
- (2014) Lili Cao et al. CURRENT MEDICINAL CHEMISTRY
- In vitro transport characteristics of EFdA, a novel nucleoside reverse transcriptase inhibitor using Caco-2 and MDCKII cell monolayers
- (2014) Wei Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pre-exposure Prophylaxis for Human Immunodeficiency Virus
- (2014) Amanda D. Castel et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Tenofovir Alafenamide Vs. Tenofovir Disoproxil Fumarate in Single Tablet Regimens for Initial HIV-1 Therapy
- (2014) Paul E. Sax et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults
- (2014) M. Markowitz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- 4′-Ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) Inhibits HIV-1 Reverse Transcriptase with Multiple Mechanisms
- (2014) Eleftherios Michailidis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Design, Synthesis, Biochemical, and Antiviral Evaluations of C6 Benzyl and C6 Biarylmethyl Substituted 2-Hydroxylisoquinoline-1,3-diones: Dual Inhibition against HIV Reverse Transcriptase-Associated RNase H and Polymerase with Antiviral Activities
- (2014) Sanjeev Kumar V. Vernekar et al. JOURNAL OF MEDICINAL CHEMISTRY
- HIV and the spectrum of human disease
- (2014) Sebastian Lucas et al. JOURNAL OF PATHOLOGY
- Human Immunodeficiency Virus Reverse Transcriptase Displays Dramatically Higher Fidelity under Physiological Magnesium Conditions In Vitro
- (2014) V. Achuthan et al. JOURNAL OF VIROLOGY
- Mutations in HIV-1 Reverse Transcriptase Affect the Errors Made in a Single Cycle of Viral Replication
- (2014) M. E. Abram et al. JOURNAL OF VIROLOGY
- Mechanism of allosteric inhibition of HIV-1 reverse transcriptase revealed by single-molecule and ensemble fluorescence
- (2014) Grant D. Schauer et al. NUCLEIC ACIDS RESEARCH
- Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavir
- (2014) H. Hayashi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Advantages of crystallographic fragment screening: Functional and mechanistic insights from a powerful platform for efficient drug discovery
- (2014) Disha Patel et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Effects of Substitutions at the 4′ and 2 Positions on the Bioactivity of 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine
- (2013) Karen A. Kirby et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Combinations of 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine with Clinically Used Antiretroviral Drugs
- (2013) Atsuko Hachiya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase and Their Interactions with the M184I Mutation on Defining Patterns of Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Rilpivirine and Etravirine
- (2013) Hong-Tao Xu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroCharacterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor
- (2013) Ming-Tain Lai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dead-end complexes contribute to the synergistic inhibition of HIV-1 RT by the combination of rilpivirine, emtricitabine, and tenofovir
- (2013) Rima Kulkarni et al. ANTIVIRAL RESEARCH
- Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses
- (2013) Bernard Côté et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults
- (2013) Peter J. Ruane et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing
- (2013) George L. Melikian et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Improving the Resistance Profile of Hepatitis C NS3/4A Inhibitors: Dynamic Substrate Envelope Guided Design
- (2013) Ayşegül Özen et al. Journal of Chemical Theory and Computation
- Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening
- (2013) Joseph D. Bauman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Snapshot of the equilibrium dynamics of a drug bound to HIV-1 reverse transcriptase
- (2013) Daniel G. Kuroda et al. Nature Chemistry
- Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation
- (2013) K. A. Jurado et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability
- (2013) Iris Usach et al. Journal of the International AIDS Society
- HIV-1 Reverse Transcription
- (2013) W.-S. Hu et al. Cold Spring Harbor Perspectives in Medicine
- HIV-1 reverse transcriptase and antiviral drug resistance. Part 1
- (2013) Kalyan Das et al. Current Opinion in Virology
- HIV-1 reverse transcriptase and antiviral drug resistance. Part 2
- (2013) Kalyan Das et al. Current Opinion in Virology
- Panel of Prototypical Recombinant Infectious Molecular Clones Resistant to Nevirapine, Efavirenz, Etravirine, and Rilpivirine
- (2012) Maya Balamane et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Response of Simian Immunodeficiency Virus to the Novel Nucleoside Reverse Transcriptase Inhibitor 4′-Ethynyl-2-Fluoro-2′-DeoxyadenosineIn VitroandIn Vivo
- (2012) Michael Murphey-Corb et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biochemical Mechanism of HIV-1 Resistance to Rilpivirine
- (2012) Kamalendra Singh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks
- (2012) Tjeerd Barf et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rational Design of Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
- (2012) Pek Chong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mechanism for Effective Lymphoid Cell and Tissue Loading Following Oral Administration of Nucleotide Prodrug GS-7340
- (2012) Darius Babusis et al. MOLECULAR PHARMACEUTICS
- HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism
- (2012) Kalyan Das et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants
- (2012) Barry C Johnson et al. Retrovirology
- The HIV-1 Reverse Transcriptase M184I Mutation Enhances the E138K-Associated Resistance to Rilpivirine and Decreases Viral Fitness
- (2011) Rima Kulkarni et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Genotypic and Phenotypic Characterization of HIV-1 Isolates Obtained From Patients on Rilpivirine Therapy Experiencing Virologic Failure in the Phase 3 ECHO and THRIVE Studies
- (2011) Laurence Rimsky et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- The resurgence of covalent drugs
- (2011) Juswinder Singh et al. NATURE REVIEWS DRUG DISCOVERY
- Residual HIV-1 DNA Flap-independent nuclear import of cPPT/CTS double mutant viruses does not support spreading infection
- (2011) Candela Iglesias et al. Retrovirology
- Structures of Reverse Transcriptase Pre- and Post-Excision Complexes Shed New Light on HIV-1 AZT Resistance
- (2011) Walter A. Scott Viruses-Basel
- Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies
- (2010) Johan Vingerhoets et al. AIDS
- Characterization of Genotypic and Phenotypic Changes in HIV-1-Infected Patients with Virologic Failure on an Etravirine-Containing Regimen in the DUET-1 and DUET-2 Clinical Studies
- (2010) Lotke Tambuyzer et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Combinations of Mutations in the Connection Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Assessing the Impact on Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitor Resistance
- (2010) S. Gupta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations
- (2010) Elizabeth C. Reuman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The N348I Mutation at the Connection Subdomain of HIV-1 Reverse Transcriptase Decreases Binding to Nevirapine
- (2010) Matthew M. Schuckmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The HIV-1 Central Polypurine Tract Functions as a Second Line of Defense against APOBEC3G/F
- (2010) C. Hu et al. JOURNAL OF VIROLOGY
- Nature, Position, and Frequency of Mutations Made in a Single Cycle of HIV-1 Replication
- (2010) M. E. Abram et al. JOURNAL OF VIROLOGY
- Evaluating the Substrate-Envelope Hypothesis: Structural Analysis of Novel HIV-1 Protease Inhibitors Designed To Be Robust against Drug Resistance
- (2010) M. N. L. Nalam et al. JOURNAL OF VIROLOGY
- Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication
- (2010) Frauke Christ et al. Nature Chemical Biology
- Structural basis of HIV-1 resistance to AZT by excision
- (2010) Xiongying Tu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and Inhibitors
- (2010) Greg L. Beilhartz et al. Viruses-Basel
- HIV virology and pathogenetic mechanisms of infection: a brief overview
- (2010) Emanuele Fanales-Belasio et al. ANNALI DELL ISTITUTO SUPERIORE DI SANITA
- TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1
- (2009) H. Azijn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)
- (2009) Marie-Pierre de Béthune ANTIVIRAL RESEARCH
- Structural Basis for the Role of the K65R Mutation in HIV-1 Reverse Transcriptase Polymerization, Excision Antagonism, and Tenofovir Resistance
- (2009) Kalyan Das et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mechanism of Inhibition of HIV-1 Reverse Transcriptase by 4′-Ethynyl-2-fluoro-2′-deoxyadenosine Triphosphate, a Translocation-defective Reverse Transcriptase Inhibitor
- (2009) Eleftherios Michailidis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small Molecule Inhibitors Targeting HIV-1 Reverse Transcriptase Dimerization
- (2008) Dina Grohmann et al. CHEMBIOCHEM
- 2′-Deoxy-4′-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants
- (2008) Atsushi Kawamoto et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against “Nucleotide-competing Reverse Transcriptase Inhibitors”
- (2008) Maryam Ehteshami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition
- (2008) Stefan G. Sarafianos et al. JOURNAL OF MOLECULAR BIOLOGY
- High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: Strategic flexibility explains potency against resistance mutations
- (2008) K. Das et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
- (2008) B. F. Keele et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Small-Molecule CD4 Mimics Interact with a Highly Conserved Pocket on HIV-1 gp120
- (2008) Navid Madani et al. STRUCTURE
- RNase H activity: Structure, specificity, and function in reverse transcription
- (2008) Sharon J. Schultz et al. VIRUS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started